ArticleHeliyon2022

Beneficial effects of SGLT2 inhibitor on metabolic inflexibility and visceral fat amount in animal model of obese type 2 diabetes.

Kento Hara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.